CROCS INC (CROX) Stock Fundamental Analysis
NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock
We assign a fundamental rating of 7 out of 10 to CROX. CROX was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CROX may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, CROX could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
In the past 5 years CROX always reported a positive cash flow from operatings.
1.2 Ratios
CROX's Return On Assets of 17.71% is amongst the best of the industry. CROX outperforms 93.88% of its industry peers.
CROX's Return On Equity of 48.39% is amongst the best of the industry. CROX outperforms 97.96% of its industry peers.
CROX has a better Return On Invested Capital (21.93%) than 89.80% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CROX is significantly above the industry average of 11.39%.
The 3 year average ROIC (30.08%) for CROX is well above the current ROIC(21.93%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.71% | ||
| ROE | 48.39% | ||
| ROIC | 21.93% |
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%
1.3 Margins
With an excellent Profit Margin value of 20.50%, CROX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CROX has declined.
CROX has a better Operating Margin (26.15%) than 100.00% of its industry peers.
CROX's Operating Margin has improved in the last couple of years.
CROX has a better Gross Margin (58.15%) than 71.43% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.15% | ||
| PM (TTM) | 20.5% | ||
| GM | 58.15% |
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%
2. Health
2.1 Basic Checks
CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CROX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
The debt/assets ratio for CROX has been reduced compared to a year ago.
2.2 Solvency
CROX has an Altman-Z score of 3.84. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
CROX has a Altman-Z score of 3.84. This is in the better half of the industry: CROX outperforms 73.47% of its industry peers.
The Debt to FCF ratio of CROX is 1.51, which is an excellent value as it means it would take CROX, only 1.51 years of fcf income to pay off all of its debts.
CROX has a Debt to FCF ratio of 1.51. This is in the better half of the industry: CROX outperforms 79.59% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that CROX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.82, CROX is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 1.51 | ||
| Altman-Z | 3.84 |
ROIC/WACC2.57
WACC8.52%
2.3 Liquidity
CROX has a Current Ratio of 1.43. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.43, CROX is doing worse than 77.55% of the companies in the same industry.
A Quick Ratio of 0.90 indicates that CROX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.90, CROX is doing worse than 67.35% of the companies in the same industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.17%, which is quite good.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.01% yearly.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 3.16% in the last year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.49% yearly.
EPS 1Y (TTM)9.17%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%10.77%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%1.58%
3.2 Future
CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.01% yearly.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 3.71% on average per year.
EPS Next Y9.44%
EPS Next 2Y4.86%
EPS Next 3Y4.83%
EPS Next 5Y1.01%
Revenue Next Year2.92%
Revenue Next 2Y2.93%
Revenue Next 3Y3.34%
Revenue Next 5Y3.71%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.82, which indicates a rather cheap valuation of CROX.
Compared to the rest of the industry, the Price/Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 97.96% of the companies listed in the same industry.
CROX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
Based on the Price/Forward Earnings ratio of 7.81, the valuation of CROX can be described as very cheap.
Based on the Price/Forward Earnings ratio, CROX is valued cheaply inside the industry as 91.84% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CROX to the average of the S&P500 Index (24.44), we can say CROX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.82 | ||
| Fwd PE | 7.81 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CROX is valued cheaply inside the industry as 91.84% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 87.76% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.4 | ||
| EV/EBITDA | 6.42 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y4.86%
EPS Next 3Y4.83%
5. Dividend
5.1 Amount
CROX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CROCS INC
NASDAQ:CROX (1/21/2025, 8:00:00 PM)
Premarket: 103.3 0 (0%)103.3
+3.33 (+3.33%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners96%
Inst Owner Change0.04%
Ins Owners2.57%
Ins Owner Change-0.64%
Market Cap6.02B
Analysts81.74
Price Target140.42 (35.93%)
Short Float %8.61%
Short Ratio3.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.09%
Min EPS beat(2)10.34%
Max EPS beat(2)13.84%
EPS beat(4)4
Avg EPS beat(4)15.92%
Min EPS beat(4)6.63%
Max EPS beat(4)32.88%
EPS beat(8)8
Avg EPS beat(8)14.84%
EPS beat(12)12
Avg EPS beat(12)15.33%
EPS beat(16)16
Avg EPS beat(16)21.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.82%
Revenue beat(4)1
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)4.37%
Revenue beat(8)3
Avg Revenue beat(8)0.12%
Revenue beat(12)6
Avg Revenue beat(12)0.54%
Revenue beat(16)10
Avg Revenue beat(16)1.74%
PT rev (1m)-0.05%
PT rev (3m)-14.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.02%
EPS NY rev (1m)0%
EPS NY rev (3m)0.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.82 | ||
| Fwd PE | 7.81 | ||
| P/S | 1.48 | ||
| P/FCF | 6.4 | ||
| P/OCF | 5.9 | ||
| P/B | 3.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.42 |
EPS(TTM)13.21
EY12.79%
EPS(NY)13.23
Fwd EY12.8%
FCF(TTM)16.13
FCFY15.62%
OCF(TTM)17.51
OCFY16.95%
SpS69.88
BVpS29.6
TBVpS-13.21
PEG (NY)0.83
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.71% | ||
| ROE | 48.39% | ||
| ROCE | 26.49% | ||
| ROIC | 21.93% | ||
| ROICexc | 23% | ||
| ROICexgc | 65.85% | ||
| OM | 26.15% | ||
| PM (TTM) | 20.5% | ||
| GM | 58.15% | ||
| FCFM | 23.09% |
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%
ROICexc(3y)34.42%
ROICexc(5y)32.34%
ROICexgc(3y)64.19%
ROICexgc(5y)51.43%
ROCE(3y)36.32%
ROCE(5y)33.17%
ROICexcg growth 3Y28.37%
ROICexcg growth 5Y5.67%
ROICexc growth 3Y-8.6%
ROICexc growth 5Y-8.68%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 1.51 | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | 121.9% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 9.46 | ||
| Cash Conversion | 90.25% | ||
| Profit Quality | 112.63% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 3.84 |
F-Score8
WACC8.52%
ROIC/WACC2.57
Cap/Depr(3y)1958.37%
Cap/Depr(5y)1235.7%
Cap/Sales(3y)21.95%
Cap/Sales(5y)14.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.17%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%10.77%
EPS Next Y9.44%
EPS Next 2Y4.86%
EPS Next 3Y4.83%
EPS Next 5Y1.01%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%1.58%
Revenue Next Year2.92%
Revenue Next 2Y2.93%
Revenue Next 3Y3.34%
Revenue Next 5Y3.71%
EBIT growth 1Y1.18%
EBIT growth 3Y61.25%
EBIT growth 5Y71.81%
EBIT Next Year2.92%
EBIT Next 3Y0.96%
EBIT Next 5Y0.91%
FCF growth 1Y155.38%
FCF growth 3Y53.59%
FCF growth 5Y51.47%
OCF growth 1Y122.43%
OCF growth 3Y51.63%
OCF growth 5Y52.13%